Epigenetic regulation of microRNA expression in Hodgkin lymphoma

References

• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215–233.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101:2999–3004.
   PubMed Web of Science ®Google Scholar
• Deng S, Calin GA, Croce CM, et al. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008;7:2643–2646.
   PubMed Web of Science ®Google Scholar
• Calin GA, Ferracin M, Cimmino A, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353:1793–1801.
   PubMed Web of Science ®Google Scholar
• Mishra PJ, Banerjee D, Bertino JR. MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell Cycle 2008;7:853–858.
   PubMed Web of Science ®Google Scholar
• He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005;435:828–833.
   PubMed Web of Science ®Google Scholar
• Suzuki HI, Yamagata K, Sugimoto K, et al. Modulation of microRNA processing by p53. Nature 2009;460:529–533.
   PubMed Web of Science ®Google Scholar
• Saito Y, Jones PA. Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 2006;5:2220–2222.
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148–1159.
   PubMed Web of Science ®Google Scholar
• Robertson KD. DNA methylation and chromatin - unraveling the tangled web. Oncogene 2002;21:5361–5379.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011;17:330–339.
   PubMed Web of Science ®Google Scholar
• Carmona FJ, Esteller M. DNA methylation in early neoplasia. Cancer Biomark 2011;9:101–111.
   Web of Science ®Google Scholar
• Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer 2009;9:15–27.
   PubMed Web of Science ®Google Scholar
• Ushmorov A, Leithauser F, Sakk O, et al. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood 2006;107:2493–2500.
   PubMed Web of Science ®Google Scholar
• Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008;105:13556–13561.
   PubMed Web of Science ®Google Scholar
• Lujambio A, Ropero S, Ballestar E, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007;67:1424–1429.
   PubMed Web of Science ®Google Scholar
• Artells R, Navarro A, Diaz T, et al. Ultrastructural and immunohistochemical analysis of intestinal myofibroblasts during the early organogenesis of the human small intestine. Anat Rec 2011;294:462–471.
   Google Scholar
• Furuta M, Kozaki KI, Tanaka S, et al. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepa-tocellular carcinoma. Carcinogenesis 2010;31:766–776.
   PubMed Web of Science ®Google Scholar
• Craig VJ, Cogliatti SB, Rehrauer H, et al. Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. Cancer Res 2011;71:3616–3624.
   PubMed Web of Science ®Google Scholar
• Tazawa H, Tsuchiya N, Izumiya M, et al. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007;104:15472–15477.
   PubMed Web of Science ®Google Scholar
• Bueno MJ, Perez de Castro I, Gomez de Cedron M, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008;13:496–506.
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe P, De Weer A, Mestdagh P, et al. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 + B-cells reveals a distinct subset of differentially expressed miRNAs. Br J Haematol 2009;147:686–690.
   PubMed Web of Science ®Google Scholar
• Gibcus JH, Tan LP, Harms G, et al. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 2009;11:167–176.
   PubMed Web of Science ®Google Scholar
• Navarro A, Gaya A, Martinez A, et al. MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 2008;111:2825–2832.
   PubMed Web of Science ®Google Scholar
• Navarro A, Diaz T, Martinez A, et al. Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood 2009;114:2945–2951.
   PubMed Web of Science ®Google Scholar
• Lodygin D, Tarasov V, Epanchintsev A, et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008;7:2591–2600.
   PubMed Web of Science ®Google Scholar
• Chim CS, Wong KY, Qi Y, et al. Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis 2010;31:745–750.
   PubMed Web of Science ®Google Scholar
• Wong KY, Liang R, So CC, et al. Epigenetic silencing of MIR203 in multiple myeloma. Br J Haematol 2011;154:569–578.
   PubMed Web of Science ®Google Scholar
• Chim CS, Wong KY, Leung CY, et al. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies. J Cell Mol Med 2011;15:2760–2767.
   PubMed Web of Science ®Google Scholar
• Chim CS, Wan TS, Wong KY, et al. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms. J Transl Med 2011;9:197.
   PubMed Web of Science ®Google Scholar
• de Souza Rocha Simonini P, Breiling A, Gupta N, et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 2010;70:9175–9184.
   PubMed Web of Science ®Google Scholar
• Grady WM, Parkin RK, Mitchell PS, et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008;27:3880–3888.
   PubMed Web of Science ®Google Scholar
• Hamfjord J, Stangeland AM, Hughes T, et al. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One 2012;7:e34150.
   PubMed Web of Science ®Google Scholar
• Tsai KW, Kao HW, Chen HC, et al. Epigenetic control of the expression of a primate-specific microRNA cluster in human cancer cells. Epigenetics 2009;4:587–592.
   PubMed Web of Science ®Google Scholar
• Saba HI. Decitabine in the treatment of myelodysplastic syndromes. Ther Clin Risk Manag 2007;3:807–817.
   PubMed Web of Science ®Google Scholar
• Hollenbach PW, Nguyen AN, Brady H, et al. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines. PLoS One 2010;5:e9001.
   PubMed Web of Science ®Google Scholar
• Ru P, Steele R, Hsueh EC, et al. Anti-miR-203 upregulates SOCS3 expression in breast cancer cells and enhances cisplatin chemosensitivity. Genes Cancer 2011;2:720–727.
   PubMedGoogle Scholar
• Hagemann S, Heil O, Lyko F, et al. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines. PLoS One 2011;6:e17388.
   PubMed Web of Science ®Google Scholar